Investigating the Effects of Ayurvedic Anti-Depressant Drug (Nardostachys Jatamansi DC.) Complementing Allopathic Medication in Patients with Major Depressive Disorder (Vishada)

Central Council for Research in Ayurveda Science0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

研究概览

暂无简介。

•Patients of Vishada according to Ayurveda parameters and Major Depressive Disorder as per ICD-10: moderate depression (HDRS scores of 17-23), prescribed with Escitalopram 10-20mg for < 2 months.
•Subjects of either gender in the age group of 18 to 45 years
•Patients willing to participate in the study and give informed written consent

•Patients suffering from any other known cardiorespiratory, neurological or endocrinological, systemic disorders as assessed by history and detailed clinical examination
•Patients suffering from other psychiatric disorders: alcohol/substance abuse, psychotic features (Anya manovaha sroto vikara), suicidal tendency (Na prana Akanksha)
•Female patients who are pregnant or lactating (Garbhini and Soothika)
•Depression with suicidal tendency/ thoughts Other psychotic disorders Cardiovascular disorders
•Patients with contraindications for TMS (Transcranial magnetic stimulation): Major head injury, epilepsy, metallic implants anywhere in the body
•Patients who have completed participation in any other clinical trial during the past six (06) months and any other condition which the Investigators think may jeopardize the study

发起方

Central Council for Research in Ayurveda Science